Sanofi-Aventis prepares generic Plavix for Europe
This article was originally published in Scrip
Executive Summary
Sanofi-Aventis is preparing to launch a generic version of its antithrombotic Plavix (clopidogrel) in Europe, the firm told Scrip. The company hopes to counter sales of generics competing with the billion dollar pharmaceutical, which is beginning to lose patent protection.